Qube Research & Technologies LTD Gossamer Bio, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 228,455 shares of GOSS stock, worth $212,463. This represents 0.0% of its overall portfolio holdings.
Number of Shares
228,455
Previous 181,638
25.77%
Holding current value
$212,463
Previous $163,000
38.65%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GOSS
# of Institutions
109Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$16.8 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$12.4 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.9 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.54 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.49 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $87.4M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...